BioCentury
ARTICLE | Strategy

Partnering on a mission

How Brii’s partnering strategy benefits investors and Chinese social good

June 2, 2018 5:29 AM UTC

With a $260 million war chest and a banner roster of execs, advisors and deals, Brii Biosciences is pushing an agenda to bring infectious diseases to the forefront of innovation in China. Its top priority is to leverage digital health data to both further the public health mission and build a sustainable company.

Last week, Arch Venture Partners and a syndicate of Chinese investors launched Brii with a strategy to take innovations developed in the west and develop them in China, Hong Kong, Macau and Taiwan, and in parallel pursue internal programs from Chinese innovations to out-license for development in the west. ...